Digest Network How does it work
Network
/
Society
Vi
Not verified

Vividion Therapeutics, Inc.

What we write about

BiotechnologyHealthMedicine - variousOncologyPharmaceuticals

6 Press releases

View all press releases
04/06/2025
Industria
Oncology
Health
Medicine - various
Scienza
Pharmaceuticals
Biotechnology
Vividion Therapeutics and Bayer Further Strengthen Oncology Development Pipeline with Clinical-Stage WRN Inhibitor
Source
Vividion Therapeutics, Inc.
Issuer
Business Wire
1.00
0
03/04/2025
Industria
Biotechnology
Health
Pharmaceuticals
Medicine - various
Oncology
Vividion Therapeutics Doses First Patient in Phase I Study of RAS-PI3Kα Inhibitor for Treatment of Advanced Solid Tumors
Source
Vividion Therapeutics, Inc.
Issuer
Business Wire
1.00
0
22/01/2025
Labour market
Biotechnology
Pharmaceuticals
Health
Oncology
Vividion Therapeutics Announces Promotion of Jean Bemis to Chief Operating Officer
Source
Vividion Therapeutics, Inc.
Issuer
Business Wire
1.00
0
08/01/2025
stock market
Industria
Tecnica
Scienza
Biotechnology
Software
Health
Pharmaceuticals
Oncology
Vividion Therapeutics Acquires Tavros Therapeutics to Expand Functional Genomics Capabilities and Boost Drug Discovery Platform
Source
Vividion Therapeutics, Inc.
Issuer
Business Wire
1.00
0
08/10/2024
Labour market
Scienza
Biotechnology
Pharmaceuticals
Oncology
Health
Medicine - various
Vividion Therapeutics Appoints Frank Poschen to Board of Directors
Source
Vividion Therapeutics, Inc.
Issuer
Business Wire
1.00
0
23/07/2024
Multimedia
Scienza
Biotechnology
Pharmaceuticals
Oncology
Health
Medicine - various
Industria
Vividion Therapeutics to Expand with New Global Research and Development Center
Source
Vividion Therapeutics, Inc.
Issuer
Business Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0